NCT00439608 Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer Status COMPLETED Phase PHASE2
NCT00439270 Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00437437 A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) Status COMPLETED Phase PHASE1
NCT00437424 A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction Status COMPLETED Phase PHASE1
NCT00435669 A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664) Status COMPLETED Phase PHASE1
NCT00430677 Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Status TERMINATED Phase PHASE2/PHASE3
NCT00430027 Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma Status TERMINATED Phase NA
NCT00423891 A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection Status COMPLETED Phase PHASE1/PHASE2
NCT00423319 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) Status COMPLETED Phase PHASE3
NCT00420199 A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3
NCT00420186 A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin Status COMPLETED Phase PHASE1
NCT00412984 Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT00411957 Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00410410 A Study of Abatacept in Patients With Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00410202 Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus Status COMPLETED Phase PHASE3
NCT00410072 Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B Status COMPLETED Phase PHASE3